Precision Medicine and Novel Therapeutic Strategies in Detection and Treatment of Cancer: Highlights from the 58th IACR Annual Conference.
cancer vaccine
early detection
epigenetics
systems biology
targeted therapeutics
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
16 Dec 2022
16 Dec 2022
Historique:
received:
26
11
2022
revised:
12
12
2022
accepted:
13
12
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
Innovation in both detection and treatment of cancer is necessary for the constant improvement in therapeutic strategies, especially in patients with novel or resistant variants of cancer. Cancer mortality rates have declined by almost 30% since 1991, however, depending on the cancer type, acquired resistance can occur to varying degrees. To combat this, researchers are looking towards advancing our understanding of cancer biology, in order to inform early detection, and guide novel therapeutic approaches. Through combination of these approaches, it is believed that a more complete and thorough intervention on cancer can be achieved. Here, we will discuss the advances and approaches in both detection and treatment of cancer, presented at the 58th Irish Association for Cancer Research (IACR) annual conference.
Identifiants
pubmed: 36551698
pii: cancers14246213
doi: 10.3390/cancers14246213
pmc: PMC9777219
pii:
doi:
Types de publication
Congress
Langues
eng
Références
Immunotherapy. 2015;7(6):683-704
pubmed: 26100270
Nature. 2019 Jul;571(7766):570-575
pubmed: 31243362
Br J Cancer. 2005 Oct 31;93(9):1019-23
pubmed: 16205698
N Engl J Med. 2020 Feb 6;382(6):503-513
pubmed: 31995683
J Immunother Cancer. 2021 Sep;9(9):
pubmed: 34479921
Discov Oncol. 2022 May 16;13(1):31
pubmed: 35576080
Cancers (Basel). 2021 Jul 16;13(14):
pubmed: 34298787
Front Med (Lausanne). 2017 Mar 08;4:18
pubmed: 28337438
Cancer Res. 2013 Jul 15;73(14):4406-17
pubmed: 23674500
Clin Cancer Res. 2004 Aug 15;10(16):5501-7
pubmed: 15328189
Mol Cell. 2005 Jul 1;19(1):89-100
pubmed: 15989967
Vaccines (Basel). 2020 Jul 16;8(3):
pubmed: 32708759
Br J Cancer. 2015 Mar 31;112 Suppl 1:S108-15
pubmed: 25734389
Lung Cancer. 2022 Jun;168:46-49
pubmed: 35487105
Nat Commun. 2016 May 10;7:11479
pubmed: 27161491
Nature. 2012 Dec 6;492(7427):108-12
pubmed: 23051747
Cell Mol Life Sci. 2020 Feb;77(4):559-572
pubmed: 31471681
Clin Cancer Res. 2016 Apr 15;22(8):1885-96
pubmed: 27084742
J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S343-S351
pubmed: 34590138
Science. 2013 Mar 29;339(6127):1546-58
pubmed: 23539594
Nat Rev Cancer. 2012 Jan 19;12(2):121-32
pubmed: 22257950
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Lancet. 2008 Feb 16;371(9612):569-78
pubmed: 18280327
ACS Omega. 2019 Jun 10;4(6):10070-10077
pubmed: 31460099
Clin Cancer Res. 2004 Apr 1;10(7):2466-72
pubmed: 15073126
Nat Commun. 2013;4:2836
pubmed: 24284865
Genes Dev. 2019 Aug 1;33(15-16):936-959
pubmed: 31123059
Nat Med. 2019 Mar;25(3):517-525
pubmed: 30664780
Cancer Discov. 2020 Oct;10(10):1489-1499
pubmed: 32690541
Nat Genet. 2012 Jan 29;44(3):251-3
pubmed: 22286216
Cancer Cell. 2020 Apr 13;37(4):496-513
pubmed: 32289273
Curr Opin Cell Biol. 2015 Dec;37:42-8
pubmed: 26497635
Curr Drug Targets. 2011 Oct;12(11):1595-653
pubmed: 21561421
Endocr Relat Cancer. 2019 May 09;26(6):R369-R380
pubmed: 32013374
Nat Genet. 2021 Aug;53(8):1221-1232
pubmed: 34294917
J Am Coll Radiol. 2019 Apr;16(4 Pt A):446-450
pubmed: 30777648
Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):584-590
pubmed: 30420441
Cell Div. 2017 Oct 27;12:7
pubmed: 29090014
N Engl J Med. 1948 Jun 3;238(23):787-93
pubmed: 18860765
J Biol Chem. 2013 Nov 22;288(47):33542-33558
pubmed: 24089526
Nature. 2012 Jan 29;482(7384):226-31
pubmed: 22286061
Lancet Oncol. 2020 Nov;21(11):1433-1442
pubmed: 33035457
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
N Engl J Med. 2009 Feb 5;360(6):626-33
pubmed: 19176475
Int J Cancer. 2021 Apr 1;148(7):1575-1585
pubmed: 33006395